Minerva Neurosciences, Inc. (NERV)
4.17
+0.05
(+1.21%)
USD |
NASDAQ |
Sep 10, 16:00
4.17
0.00 (0.00%)
After-Hours: 18:10
Minerva Neurosciences Market Cap : 196.94M for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 194.58M |
| September 08, 2026 | 206.38M |
| September 04, 2026 | 209.22M |
| September 03, 2026 | 221.50M |
| September 02, 2026 | 211.58M |
| September 01, 2026 | 211.58M |
| August 31, 2026 | 215.36M |
| August 28, 2026 | 228.58M |
| August 27, 2026 | 242.28M |
| August 26, 2026 | 256.44M |
| August 25, 2026 | 236.14M |
| August 24, 2026 | 227.16M |
| August 21, 2026 | 228.58M |
| August 20, 2026 | 226.22M |
| August 19, 2026 | 226.22M |
| August 18, 2026 | 214.41M |
| August 17, 2026 | 208.74M |
| August 14, 2026 | 216.30M |
| August 13, 2026 | 185.13M |
| August 12, 2026 | 185.13M |
| August 11, 2026 | 204.02M |
| August 10, 2026 | 218.19M |
| August 07, 2026 | 201.66M |
| August 06, 2026 | 209.69M |
| August 05, 2026 | 205.44M |
| Date | Value |
|---|---|
| August 04, 2026 | 190.80M |
| August 03, 2026 | 174.05M |
| July 31, 2026 | 174.49M |
| July 30, 2026 | 176.24M |
| July 29, 2026 | 179.31M |
| July 28, 2026 | 187.64M |
| July 27, 2026 | 184.36M |
| July 24, 2026 | 177.12M |
| July 23, 2026 | 195.10M |
| July 22, 2026 | 194.22M |
| July 21, 2026 | 196.41M |
| July 20, 2026 | 191.59M |
| July 17, 2026 | 187.21M |
| July 16, 2026 | 184.57M |
| July 15, 2026 | 189.40M |
| July 14, 2026 | 176.24M |
| July 13, 2026 | 187.21M |
| July 10, 2026 | 206.93M |
| July 09, 2026 | 206.93M |
| July 08, 2026 | 202.55M |
| July 07, 2026 | 209.13M |
| July 06, 2026 | 215.70M |
| July 02, 2026 | 223.59M |
| July 01, 2026 | 225.79M |
| June 30, 2026 | 243.32M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.775B |
| Alnylam Pharmaceuticals, Inc. | 33.10B |
| Anika Therapeutics, Inc. | 280.71M |
| Savara, Inc. | 1.093B |
| Vericel Corp. | 1.938B |
Market Cap Related Metrics
| Price | 4.17 |
| Earnings Yield | -692.4% |